Moviprep patents expiration

MOVIPREP's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7169381 SALIX PHARMS Colon cleansing compositions and methods
Sep, 2024

(11 months from now)

US7658914 SALIX PHARMS Colon cleansing compositions
Sep, 2024

(11 months from now)

Moviprep is owned by Salix Pharms.

Moviprep contains Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate.

Moviprep has a total of 2 drug patents out of which 0 drug patents have expired.

Moviprep was authorised for market use on 02 August, 2006.

Moviprep is available in for solution;oral dosage forms.

The generics of Moviprep are possible to be released after 01 September, 2024.

How can I launch a generic of MOVIPREP before it's drug patent expiration?
More Information on Dosage

MOVIPREP family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic